Cambrex Charles City, Inc., a subsidiary of Cambrex Corporation, manufactures Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates for both the generic and branded human pharmaceutical markets.
Due to increased business opportunities, Cambrex has identified the need for a capital expansion to increase manufacturing capacity.
The Iowa Economic Development Authority awarded the company $368,000 in direct financial assistance as well as tax benefits to build a new facility. This $17 million capital investment is expected to create 46 jobs.